|

Zedoresertib Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Debio 0123

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • Debiopharm International SA2

Indications

  • Cancer2
  • Astrocytoma, Grade III1
  • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype1
  • Advanced Solid Tumor1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.